BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

45

References

230

Citations